Altimmune Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Altimmune
ALT Stock  USD 3.61  0.07  1.90%   
Analyzing historical trends in various income statement and balance sheet accounts from Altimmune's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Altimmune's valuation are summarized below:
Gross Profit
-67.8 M
Market Capitalization
376.7 M
Enterprise Value Revenue
9.1 K
Revenue
20 K
Earnings Share
(1.07)
There are currently one hundred twenty fundamental signals for Altimmune that can be evaluated and compared over time across rivals. All traders should validate Altimmune's prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 537.5 M in 2025. Enterprise Value is likely to gain to about 500.5 M in 2025

Altimmune Total Revenue

19,000

Check Altimmune financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Altimmune's main balance sheet or income statement drivers, such as Interest Expense of 8.6 K, Selling General Administrative of 14 M or Total Revenue of 19 K, as well as many indicators such as Price To Sales Ratio of 26.9 K, Dividend Yield of 23.4 or PTB Ratio of 4.35. Altimmune financial statements analysis is a perfect complement when working with Altimmune Valuation or Volatility modules.
  
Build AI portfolio with Altimmune Stock
Check out the analysis of Altimmune Correlation against competitors.
For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.

Altimmune Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets101.6 M139.3 M105.9 M
Slightly volatile
Other Current Liabilities17.6 M10 M18.3 M
Very volatile
Total Current Liabilities20.7 M10.5 M20.7 M
Very volatile
Total Stockholder Equity74.8 M123.5 M81.5 M
Slightly volatile
Accounts Payable200.4 K211 K1 M
Pretty Stable
Cash51.7 M36.9 M57.3 M
Slightly volatile
Cash And Short Term Investments76.2 M131.9 M85.5 M
Slightly volatile
Common Stock Total Equity3.9 K4.7 K4 K
Very volatile
Common Stock Shares Outstanding74.6 M71 M20.6 M
Slightly volatile
Liabilities And Stockholders Equity101.6 M139.3 M105.9 M
Slightly volatile
Other Current Assets2.1 M2.2 M997 M
Pretty Stable
Other Stockholder Equity724.4 M689.9 M329 M
Slightly volatile
Total Liabilities26.8 M15.8 M24.3 M
Very volatile
Total Current Assets92.6 M137.3 M97 M
Slightly volatile
Common Stock4.4 K8.1 K4.5 K
Pretty Stable
Net Receivables4.7 M3.1 M4.5 M
Very volatile
Non Current Liabilities Total4.7 M5.3 M4.4 M
Very volatile
Short Term Debt265.1 K279 K700.8 K
Slightly volatile
Short and Long Term Debt Total1.6 M1.7 M3.3 M
Slightly volatile
Property Plant And Equipment Net392.4 K413 K1.2 M
Slightly volatile
Non Current Assets Total1.9 M2.1 M9 M
Very volatile
Non Currrent Assets Other1.7 M1.6 M556 K
Slightly volatile
Property Plant And Equipment Gross1.6 M2.4 M1.6 M
Very volatile
Net Tangible Assets208.7 M198.8 M82.6 M
Slightly volatile
Capital Surpluse600.5 M571.9 M308.5 M
Slightly volatile
Property Plant Equipment2 M1.9 M999.4 K
Slightly volatile
Long Term Debt Total2 M1.7 M1.6 M
Pretty Stable
Non Current Liabilities Other2.1 M3.9 M1.7 M
Slightly volatile
Other Liabilities3.3 M4.5 M2.5 M
Slightly volatile
Short and Long Term Debt61.2 K64.4 K436.1 K
Slightly volatile
Warrants7.4 M8.4 M9.1 M
Slightly volatile
Net Invested Capital146.1 M123.5 M93 M
Slightly volatile
Net Working Capital136.7 M126.8 M79.3 M
Slightly volatile
Capital Stock4.6 K8.1 K2.6 K
Slightly volatile
Capital Lease Obligations1.1 M1.7 M1.6 M
Slightly volatile

Altimmune Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative14 M21 M12.1 M
Slightly volatile
Other Operating Expenses108.4 M103.2 M48.5 M
Slightly volatile
Total Operating Expenses108.4 M103.2 M46.4 M
Slightly volatile
Depreciation And Amortization344.6 K238 K336.9 K
Very volatile
Research Development86.3 M82.2 M36 M
Slightly volatile
Non Recurring18 M13.1 M11.8 M
Slightly volatile
Interest Income8.5 M8.1 M1.8 M
Slightly volatile
Preferred Stock And Other Adjustments387.3 K407.6 K2.9 M
Slightly volatile
Selling And Marketing Expenses226254277
Slightly volatile

Altimmune Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities9.5 M10 M37.9 M
Pretty Stable
End Period Cash Flow52 M37 M57.6 M
Slightly volatile
Begin Period Cash Flow141.9 M135.2 M52.2 M
Slightly volatile
Depreciation339.1 K238 K328.9 K
Very volatile
Stock Based Compensation15.1 M14.4 M4.6 M
Slightly volatile
Issuance Of Capital Stock9.5 M10 M46.8 M
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield23.426.3228.6981
Slightly volatile
PTB Ratio4.354.1451.9422
Slightly volatile
Book Value Per Share1.651.7395206
Slightly volatile
Average Payables1.4 M1.5 M1.2 M
Slightly volatile
Capex To Depreciation0.08420.08872.0105
Pretty Stable
PB Ratio4.354.1451.9422
Slightly volatile
Payables Turnover1.071.12880.9399
Very volatile
Average Inventory190.6 K214.4 K233.8 K
Slightly volatile
Cash Per Share1.761.857590.8634
Pretty Stable
Days Payables Outstanding376324382
Slightly volatile
Income Quality0.950.840.8751
Slightly volatile
Intangibles To Total Assets0.05130.0540.2554
Pretty Stable
Current Ratio20.6313.111819.6034
Slightly volatile
Shareholders Equity Per Share1.651.7395206
Slightly volatile
Debt To Equity0.01290.01360.1126
Slightly volatile
Capex Per Share0.0010.0011.9737
Slightly volatile
Average Receivables7.4 M10.5 M7 M
Slightly volatile
Interest Debt Per Share0.02260.023849.0539
Slightly volatile
Debt To Assets0.01150.01210.0619
Slightly volatile
Graham Number7731.1 K1.2 K
Very volatile
Price Book Value Ratio4.354.1451.9422
Slightly volatile
Days Of Payables Outstanding376324382
Slightly volatile
Company Equity Multiplier1.071.12791.9296
Pretty Stable
Long Term Debt To Capitalization0.01120.01180.0428
Slightly volatile
Total Debt To Capitalization0.01280.01340.0847
Slightly volatile
Debt Equity Ratio0.01290.01360.1126
Slightly volatile
Quick Ratio12.4613.111827.0631
Pretty Stable
Net Income Per E B T0.580.90.8749
Pretty Stable
Cash Ratio3.413.52755.0529
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.820.91.0088
Slightly volatile
Price To Book Ratio4.354.1451.9422
Slightly volatile
Debt Ratio0.01150.01210.0619
Slightly volatile
Price Fair Value4.354.1451.9422
Slightly volatile

Altimmune Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap537.5 M511.9 M206.2 M
Slightly volatile

Altimmune Fundamental Market Drivers

Altimmune Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Altimmune Financial Statements

Altimmune shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Altimmune investors may analyze each financial statement separately, they are all interrelated. The changes in Altimmune's assets and liabilities, for example, are also reflected in the revenues and expenses on on Altimmune's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue 1.15  1.09 
Total Revenue20 K19 K
Cost Of Revenue238 K226.1 K
Stock Based Compensation To Revenue 719.65  755.63 
Sales General And Administrative To Revenue1 K1.1 K
Research And Ddevelopement To Revenue4.1 K4.3 K
Capex To Revenue 0.10  0.09 
Ebit Per Revenue-5.2 K-4.9 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Altimmune Stock Analysis

When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY